Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Nov;18(5):696–698. doi: 10.1128/aac.18.5.696

Relative resistance to erythromycin in Chlamydia trachomatis.

A Mourad, R L Sweet, N Sugg, J Schachter
PMCID: PMC284078  PMID: 7447426

Abstract

Recent Chlamydia trachomatis isolates were tested in a tissue culture system for susceptibility to tetracycline, erythromycin, rosaramicin, rifampin, and clindamycin. Rifampin was the most active drug (minimal inhibitory concentration, less than or equal to 0.02 microgram/ml). Tetracycline and rasaramicin were highly active, with a concentration of less than or equal to 0.25 microgram/ml being chlamydicidal. Clindamycin was least active on a weight basis, requiring up to 16 microgram/ml to prevent the passage of chlamydiae into a drug-free tissue culture system. Relative resistance to erythromycin was detected; two isolates were capable of limited replication in 1 microgram/ml.

Full text

PDF
696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker Y., Asher Y., Himmel N., Zakay-Rones Z., Maythar B. Rifapicin inhibition of trachoma agent in vivo. Nature. 1969 Oct 4;224(5214):33–34. doi: 10.1038/224033a0. [DOI] [PubMed] [Google Scholar]
  2. Blackman H. J., Yoneda C., Dawson C. R., Schachter J. Antibiotic susceptibility of Chlamydia trachomatis. Antimicrob Agents Chemother. 1977 Dec;12(6):673–677. doi: 10.1128/aac.12.6.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bowie W. R., Lee C. K., Alexander E. R. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis. J Infect Dis. 1978 Nov;138(5):655–659. doi: 10.1093/infdis/138.5.655. [DOI] [PubMed] [Google Scholar]
  4. Keshishyan H., Hanna L., Jawetz E. Emergence of rifampin-resistance in Chlamydia trachomatis. Nature. 1973 Jul 20;244(5412):173–174. doi: 10.1038/244173a0. [DOI] [PubMed] [Google Scholar]
  5. Kuo C. C., Wang S. P., Grayston J. T. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother. 1977 Jul;12(1):80–83. doi: 10.1128/aac.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ridgway G. L., Owen J. M., Oriel J. D. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system. J Antimicrob Chemother. 1976 Mar;2(1):71–76. doi: 10.1093/jac/2.1.71. [DOI] [PubMed] [Google Scholar]
  7. Schachter J. Chlamydial infections (third of three parts). N Engl J Med. 1978 Mar 9;298(10):540–549. doi: 10.1056/NEJM197803092981005. [DOI] [PubMed] [Google Scholar]
  8. Smith T. F., Washton H. E. In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin. Antimicrob Agents Chemother. 1978 Sep;14(3):493–494. doi: 10.1128/aac.14.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wang S. P., Grayston J. T. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol. 1970 Sep;70(3):367–374. doi: 10.1016/0002-9394(70)90096-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES